Pathology and Molecular Diagnostics in the Personalized Treatment of Lung Diseases

Dear Colleagues,

As you well know, personalized medicine is a radical evolution in diagnostic, prognostic, and therapeutic approaches for patient management. Specific molecular profiles and phenotypes are linked to tailored diagnoses and therapies. The application of new technologies in better defining phenotypes and genotypes is often the scientific rationale to tailor both prevention and therapy in subsets of patients who effectively respond to specific treatments, permitting the rationalization of the economic resources of health systems.

The aim of this Special Issue of the JPM is to permit all researchers involved in the diagnosis and therapy of neoplastic as well as non-neoplastic diseases of the lung to share their experiences with diagnostic biomarkers and new predictive factors, and ultimately to determine more effective treatments.

Original and review articles on the use of novel technologies and the role of new biomarkers, observational studies on specific pathologies, as well as the better characterization of old and new pathological entities are all welcome to be submitted to this Special Issue.

We hope that this widely open Special Issue will attract several researchers to share their observations in the field of neoplastic as well as non-neoplastic diseases of the lung.

Dr. Andrea Ambrosini-Spaltro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• lung
• tumor
• biomarkers
• interstitial lung diseases
• molecular
• infections